Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade

References

• MearaJGLeatherAJHaganderLGlobal Surgery 2030: evidence and solutions for achieving health, welfare, and economic developmentLancet2015386999356962425924834
   PubMed Web of Science ®Google Scholar
• MurphyGSSzokolJWAvramMJNeostigmine administration after spontaneous recovery to a train-of-four ratio of 0.9 to 1.0: a randomized controlled trial of the effect on neuromuscular and clinical recoveryAnesthesiology20181281273728953501
   PubMed Web of Science ®Google Scholar
• DebaeneBPlaudBDillyMPDonatiFResidual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of actionAnesthesiology20039851042104812717123
   PubMed Web of Science ®Google Scholar
• BaillardCGehanGReboul-MartyJLarmignatPSamamaCMCupaMResidual curarization in the recovery room after vecuroniumBr J Anaesth200084339439510793602
   PubMed Web of Science ®Google Scholar
• BrullSJKopmanAFCurrent status of neuromuscular reversal and monitoring: challenges and opportunitiesAnesthesiology2017126117319027820709
   PubMed Web of Science ®Google Scholar
• ArbousMSMeursingAEvan KleefJWImpact of anesthesia management characteristics on severe morbidity and mortalityAnesthesiology2005102225726815681938
   PubMed Web of Science ®Google Scholar
• BulkaCMTerekhovMAMartinBJDmochowskiRRHayesRMEhrenfeldJMNondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumoniaAnesthesiology2016125464765527496656
   PubMed Web of Science ®Google Scholar
• MurphyGSDe BoerHDErikssonLIMillerRDReversal (antagonism) of neuromuscular blockadeMillerRDCohenNHErikssonLIFleisherLAWiener-KronishJPYoungWLMiller’s Anesthesia8th edPhiladelphiaElsevier20159951027
   Google Scholar
• VymazalTKrecmerovaMBicekVLischkeRFeasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery – a series of 117 casesTher Clin Risk Manag2015111593159626508869
   PubMed Web of Science ®Google Scholar
• MontagueJHalloranCReversing non-depolarising muscle relaxants, nausea and residual curarisationAnaesthesia2016714478
   Web of Science ®Google Scholar
• PatonFPauldenMChambersDSugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluationBr J Anaesth2010105555856720935005
   PubMed Web of Science ®Google Scholar
• CronnellyRStanskiDRMillerRDSheinerLBSohnYJRenal function and the pharmacokinetics of neostigmine in anesthetized manAnesthesiology1979513222226382915
   PubMed Web of Science ®Google Scholar
• MorrisRBCronnellyRMillerRDStanskiDRFaheyMRPharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in manAnesthesiology19815453994027224209
   PubMed Web of Science ®Google Scholar
• BerkóSSzűcsKFBalázsBElectroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administrationDrug Des Devel Ther20161016951701
   PubMed Web of Science ®Google Scholar
• KirkegaardHHeierTCaldwellJEEfficacy of tactile-guided reversal from cisatracurium-induced neuromuscular blockAnesthesiology2002961455011753000
   PubMed Web of Science ®Google Scholar
• LienCANeostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?Anesthesiology20101121161819952723
   PubMed Web of Science ®Google Scholar
• BrullSJMurphyGSResidual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weaknessAnesth Analg2010111112914020442261
   PubMed Web of Science ®Google Scholar
• MaybauerDMGeldnerGBlobnerMIncidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuroniumAnaesthesia2007621121717156221
   PubMed Web of Science ®Google Scholar
• PietraszewskiPGaszyńskiTResidual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuroniumAnaesthesiol Intensive Ther2013452778123877899
   PubMedGoogle Scholar
• KopmanAFEikermannMAntagonism of non-depolarising neuromuscular block: current practiceAnaesthesia200964Suppl 1223019222428
   PubMed Web of Science ®Google Scholar
• MillerRDWardTAMonitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routineAnesth Analg201011113520576958
   PubMed Web of Science ®Google Scholar
• NaguibMKopmanAFLienCAHunterJMLopezABrullSJA survey of current management of neuromuscular block in the United States and EuropeAnesth Analg2010111111011919910616
   PubMed Web of Science ®Google Scholar
• PayneJPHughesRAl AzawiSNeuromuscular blockade by neostigmine in anaesthetized manBr J Anaesth198052169767378232
   PubMed Web of Science ®Google Scholar
• GoldhillDRWainwrightAPStuartCSFlynnPJNeostigmine after spontaneous recovery from neuromuscular blockade. Effect on depth of blockade monitored with train-of-four and tetanic stimuliAnaesthesia19894442932992719200
   PubMed Web of Science ®Google Scholar
• MeyerMJBatemanBTKurthTEikermannMNeostigmine reversal doesn’t improve postoperative respiratory safetyBMJ2013346f146023512446
   PubMed Web of Science ®Google Scholar
• Grosse-SundrupMHennemanJPSandbergWSIntermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort studyBMJ2012345e632923077290
   PubMed Web of Science ®Google Scholar
• SasakiNMeyerMJMalviyaSAEffects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective studyAnesthesiology2014121595996825225821
   PubMed Web of Science ®Google Scholar
• FortierLPMcKeenDTurnerKThe RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockadeAnesth Analg2015121236637225902322
   PubMed Web of Science ®Google Scholar
• BronsertMRHendersonWGMonkTGIntermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survivalAnesth Analg201712451476148328244947
   PubMed Web of Science ®Google Scholar
• ChoiESOhAYSeoKSOptimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracuriumAnaesthesia201671444344926874258
   PubMed Web of Science ®Google Scholar
• Fuchs-BuderTNeostigmine: timing and dosing in 2016Anaesth Crit Care Pain Med201635424524727475831
   PubMed Web of Science ®Google Scholar
• Fuchs-BuderTNemesRSchmartzDResidual neuromuscular blockade: management and impact on postoperative pulmonary outcomeCurr Opin Anaesthesiol201629666266727755128
   PubMed Web of Science ®Google Scholar
• PrescottFOrganeGRowbothamSTubocurarine chloride as an adjunct to anaesthesia; report on 180 casesLancet194626412808420992919
   PubMed Web of Science ®Google Scholar
• GrayTCWilsonFThe development and use of muscle relaxants in the United KingdomAnesthesiology195920451952913670492
   PubMed Web of Science ®Google Scholar
• Viby-MogensenJJørgensenBCOrdingHResidual curarization in the recovery roomAnesthesiology1979506539541156513
   PubMed Web of Science ®Google Scholar
• Fuchs-BuderTMeistelmanCAllaFGrandjeanAWuthrichYDonatiFAntagonism of low degrees of atracurium-induced neuromuscular blockade: dose–effect relationship for neostigmineAnesthesiology20101121344019952724
   PubMed Web of Science ®Google Scholar
• HarperNJWallaceMHallIAOptimum dose of neostigmine at two levels of atracurium-induced neuromuscular blockBr J Anaesth199472182858110558
   PubMed Web of Science ®Google Scholar
• HunterJMIs it always necessary to antagonize residual neuromuscular block? Do children differ from adults?Br J Anaesth19967767077099014619
   PubMed Web of Science ®Google Scholar
• KaufholdNSchallerSJStäubleCGSugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†Br J Anaesth2016116223324026787792
   PubMed Web of Science ®Google Scholar
• MagorianTTLynamDPCaldwellJEMillerRDCan early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?Anesthesiology19907334104141975484
   PubMed Web of Science ®Google Scholar
• McCourtKCMirakhurRKKerrCMDosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recoveryAnaesthesia199954765165510417456
   PubMed Web of Science ®Google Scholar
• LedererWReinerTKhuenl-BradyKSNeostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular functionJ Clin Anesth201022642042420868962
   PubMed Web of Science ®Google Scholar
• JonesJEParkerCJHunterJMAntagonism of blockade produced by atracurium or vecuronium with low doses of neostigmineBr J Anaesth19886155605642905146
   PubMed Web of Science ®Google Scholar
• SchallerSJFinkHUlmKBlobnerMSugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular blockAnesthesiology201011351054106020885293
   PubMed Web of Science ®Google Scholar
• Fuchs-BuderTBaumannCDe GuisJGuerciPMeistelmanCLow-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: a randomised controlled trialEur J Anaesthesiol2013301059459823803594
   PubMed Web of Science ®Google Scholar
• EikermannMHouleTTAntagonism of neuromuscular block: all things are poison; only the dose makes a thing not a poisonBr J Anaesth2016116215715926787785
   PubMed Web of Science ®Google Scholar
• McLeanDJDiaz-GilDFarhanHNLadhaKSKurthTEikermannMDose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complicationsAnesthesiology201512261201121325919486
   PubMed Web of Science ®Google Scholar
• EikermannMFassbenderPMalhotraAUnwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle functionAnesthesiology2007107462162917893459
   PubMed Web of Science ®Google Scholar
• KimKSCheongMALeeHJLeeJMTactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesiaAnesth Analg20049941080108515385354
   PubMed Web of Science ®Google Scholar
• BrullSJNaguibMHow to catch unicorns (and other fairytales)Anesthesiology201812811329068828
   PubMed Web of Science ®Google Scholar
• AstleyBAKatzRLPayneJPElectrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophoniumBr J Anaesth19875989839882888476
   PubMed Web of Science ®Google Scholar
• CaldwellJEReversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuroniumAnesth Analg1995806116811747762847
   PubMed Web of Science ®Google Scholar
• EikermannMZarembaSMalhotraAJordanASRosowCChamberlinNLNeostigmine but not sugammadex impairs upper airway dilator muscle activity and breathingBr J Anaesth2008101334434918559352
   PubMed Web of Science ®Google Scholar
• HerbstreitFZigrahnDOchterbeckCPetersJEikermannMNeostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressureAnesthesiology201011361280128820980910
   PubMed Web of Science ®Google Scholar
• CaldwellJEClinical limitations of acetylcholinesterase antagonistsJ Crit Care2009241212819272535
   PubMed Web of Science ®Google Scholar
• Kirkegaard-NielsenHHelbo-HansenHSLindholmPSeverinsenIKPedersenHSJensenEWOptimum time for neostigmine reversal of atracurium-induced neuromuscular blockadeCan J Anaesth19964399329388874911
   PubMed Web of Science ®Google Scholar
• EngbaekJOstergaardDSkovgaardLTViby-MogensenJReversal of intense neuromuscular blockade following infusion of atracuriumAnesthesiology19907258038062160206
   PubMed Web of Science ®Google Scholar
• JonesRKCaldwellJEBrullSJSotoRGReversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmineAnesthesiology2008109581682418946293
   PubMed Web of Science ®Google Scholar
• LemmensHJEl-OrbanyMIBerryJMorteJBJrMartinGReversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmineBMC Anesthesiol201010151520809967
   PubMed Web of Science ®Google Scholar
• CaldwellJERobertsonENBairdWLAntagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophoniumBr J Anaesth19865811128512892877681
   PubMed Web of Science ®Google Scholar
• PlaudBDebaeneBDonatiFMartyJResidual paralysis after emergence from anesthesiaAnesthesiology201011241013102220234315
   PubMed Web of Science ®Google Scholar
• TajaateNSchreiberJUFuchs-BuderTJeltingYKrankePNeostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic reviewEur J Anaesthesiol201835318419229189420
   PubMed Web of Science ®Google Scholar
• DubovoyTHouseyMDevineSKheterpalSObservational study on patterns of neuromuscular blockade reversalBMC Anesthesiol201616110327770778
   PubMed Web of Science ®Google Scholar
• HristovskaAMDuchPAllingstrupMAfshariAEfficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adultsCochrane Database Syst Rev20178CD01276328806470
   PubMed Web of Science ®Google Scholar
• SongIASeoKSOhAYTiming of reversal with respect to three nerve stimulator end-points from cisatracurium-induced neuromuscular blockAnaesthesia201570779780226580249
   PubMed Web of Science ®Google Scholar
• FoxMAKeensSJUttingJENeostigmine in the antagonism of the action of atracuriumBr J Anaesth19875944684723566998
   PubMed Web of Science ®Google Scholar
• OstheimerGWA comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromuscular block with neostigmineAnesth Analg1977562182186322545
   PubMed Web of Science ®Google Scholar
• TramèrMRFuchs-BuderTOmitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic reviewBr J Anaesth199982337938610434820
   PubMed Web of Science ®Google Scholar
• Abad-GurumetaARipollés-MelchorJCasans-FrancésRA systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockadeAnaesthesia201570121441145226558858
   PubMed Web of Science ®Google Scholar
• ChengCRSesslerDIApfelCCDoes neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?Anesth Analg200510151349135516243993
   PubMed Web of Science ®Google Scholar
• MurphyGSSzokolJWAvramMJResidual neuromuscular block in the elderly: incidence and clinical implicationsAnesthesiology201512361322133626448469
   PubMed Web of Science ®Google Scholar
• YoungWLMatteoRSOrnsteinEDuration of action of neostigmine and pyridostigmine in the elderlyAnesth Analg19886787757783394965
   PubMed Web of Science ®Google Scholar
• CopeTMHunterJMSelecting neuromuscular-blocking drugs for elderly patientsDrugs Aging200320212514012534313
   PubMed Web of Science ®Google Scholar
• MarshRHChmielewskiATGoatVARecovery from pancuronium. A comparison between old and young patientsAnaesthesia19803512119311966257134
   PubMed Web of Science ®Google Scholar
• YoungWLBackusWMatteoRSOrnsteinEDiazJPharmacokinetics and pharmacodynamics of neostigmine in the elderly [abstract]Anesthesiology1984613AA300
   Google Scholar
• ChmielewskiATLoachABGoatVARecovery from neuromuscular blockade. A comparison between old and young patientsAnaesthesia1978336539542686316
   PubMed Web of Science ®Google Scholar
• Koscielniak-NielsenZJLaw-MinJCDonatiFBevanDRClementPWiseRDose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patientsAnesth Analg19927468458501534472
   PubMed Web of Science ®Google Scholar
• McCarthyGJCooperRStanleyJCMirakhurRKDose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderlyBr J Anaesth19926932812831356398
   PubMed Web of Science ®Google Scholar
• MuravchickSOwensWDFeltsJAGlycopyrrolate and cardiac dysrhythmias in geriatric patients after reversal of neuromuscular blockadeCan Anaesth Soc J19792612225761109
   PubMedGoogle Scholar
• OwensWDWaldbaumLSStephenCRCardiac dysrhythmia following reversal of neuromuscular blocking agents in geriatric patientsAnesth Analg1978572186190565156
   PubMed Web of Science ®Google Scholar
• MirakhurRKAntagonism of neuromuscular block in the elderly. A comparison of atropine and glycopyrronium in a mixture with neostigmineAnaesthesia19854032542583993883
   PubMed Web of Science ®Google Scholar
• LedowskiTO’DeaBMeyerkortLHegartyMVon Ungern-SternbergBSPostoperative residual neuromuscular paralysis at an Australian tertiary children’s hospitalAnesthesiol Res Pract2015201541024826064105
   PubMedGoogle Scholar
• CookDRMuscle relaxants in infants and childrenAnesth Analg19816053353436261612
   PubMed Web of Science ®Google Scholar
• BushGHSteadALThe use of d-tubocurarine in neonatal anaesthesiaBr J Anaesth19623472172814017296
   PubMed Web of Science ®Google Scholar
• FisherDMCronnellyRMillerRDSharmaMThe neuromuscular pharmacology of neostigmine in infants and childrenAnesthesiology19835932202256309036
   PubMed Web of Science ®Google Scholar
• BevanJCPurdayJPReimerEJBevanDRReversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in childrenCan J Anaesth19944111107410807828255
   PubMed Web of Science ®Google Scholar
• AbdulatifMMowafiHAl-GhamdiAEl-SanabaryMDose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adultsBr J Anaesth19967767107159014620
   PubMed Web of Science ®Google Scholar
• MeakinGSweetPTBevanJCBevanDRNeostigmine and edrophonium as antagonists of pancuronium in infants and childrenAnesthesiology19835943163216311057
   PubMed Web of Science ®Google Scholar
• GwinnuttCLWalkerRWMeakinGAntagonism of intense atracurium-induced neuromuscular block in childrenBr J Anaesth199167113161859751
   PubMed Web of Science ®Google Scholar
• BlackGWMirakhurRKKeiltySRLoveSHReversal of non-depolarising neuromuscular block in children: a comparison of atropine and glycopyrrolate in a mixture with neostigmineAnaesthesia19803599139167446931
   PubMed Web of Science ®Google Scholar
• DebaeneBMeistelmanCD’HollanderARecovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesiaAnesthesiology19897168408442574016
   PubMed Web of Science ®Google Scholar
• MotschJLeuwerMBöttigerBWBachASchönstedtRMartinEDose-response, time-course of action and recovery of rocuronium bromide in children during halothane anaesthesiaEur J Anaesthesiol Suppl19951173788557011
   PubMedGoogle Scholar
• LiuJChengZComparison of neostigmine induced reversal of rocuronium in different age childrenZhonghua Yi Xue Za Zhi2016961080781127055643
   PubMedGoogle Scholar
• FisherDMCronnellyRSharmaMMillerRDClinical pharmacology of edrophonium in infants and childrenAnesthesiology19846144284336486504
   PubMed Web of Science ®Google Scholar
• CookDRPaediatric anaesthesia: pharmacological considerationsDrugs1976123212221789047
   PubMed Web of Science ®Google Scholar
• YangLYangDLiQZuoYLuDNeostigmine for reversal of neuromuscular block in paediatric patientsCochrane Database Syst Rev201455CD010110
   Google Scholar